The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-cross-over activity of regorafenib (RE) in soft tissue sarcoma: Analysis from the REGOSARC trial.
 
Nuria Kotecki
No Relationships to Disclose
 
Thomas Brodowicz
Honoraria - Amgen; Bayer; Eisai; Novartis; PharmaMar; Roche
Consulting or Advisory Role - Amgen; Bayer; Eisai; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Axel Le Cesne
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Jennifer Wallet
No Relationships to Disclose
 
Antoine Italiano
No Relationships to Disclose
 
Jean-Yves Blay
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Christine Chevreau
No Relationships to Disclose
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
S Bastien Salas
No Relationships to Disclose
 
Christophe Perrin
No Relationships to Disclose
 
Corinne Delcambre
No Relationships to Disclose
 
Bernadette Lieg-Atzwanger
No Relationships to Disclose
 
Maud Toulmonde
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Julien Thery
No Relationships to Disclose
 
Olivier Mir
No Relationships to Disclose
 
Nicolas Penel
No Relationships to Disclose